Company says it has isolated virus strains for research
Shenzhen Kangtai Biological Products Co has successfully isolated multiple strains of the Delta variant of the coronavirus in a step that could lead to improved vaccines, media reported on Wednesday.
The report by Shenzhen Special Zone Daily quoted a company executive as saying quality requirements for human vaccines will be strictly followed in the evaluation of the isolated strains.
"In response to new challenges in global epidemic prevention and control, Kangtai will fully promote the R&D and industrialization of the vaccine against the coronavirus variant," the executive said, adding that the inactivated COVID-19 vaccine developed by the company and approved for emergency use in China, is still protective and produces a good immune response to a variety of coronavirus variants.
- Shenzhou XVIII successfully launched
- The Shenzhou XVIII spaceship successfully launched
- Xi calls on Chongqing to write its chapter in Chinese modernization
- Shandong produce seller begs for order cancellations after pricing error
- Zhejiang woman receives lenient sentence for rooftop poppy plantation
- Lucky mistake: Lottery player wins jackpot thanks to salesperson's error